ClC‐3 has been shown to actively participate in various cancers, facilitating the aggressiveness and metastasis of various types of malignancies, including breast, cervical, prostate, and nasopharyngeal cancers and glioma tumours.28, 29, 30, 31, 32, 33. The gene discussed is CLCN3; the disease is cancer.